Showing results (141-150 of 204) with videos related to

Sort By:
Pageof 21
Rheumatology and Therapy|October 9, 2022
Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 StudyBernard G Combe, Yoshiya Tanaka, Maya H Buch, et al.
Advances in Rheumatology (London, England)|August 26, 2024
Challenges in implementing treat-to-target in rheumatoid arthritis: a perspective from Brazilian rheumatologistsAdriana Maria Kakehasi, Angela Luzia Branco Pinto Duarte, Claiton Viegas Brenol, et al.
Clinical Rheumatology|May 10, 2022
Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational studyRieke Alten, Xavier Mariette, René-Marc Flipo, et al.
Trials|January 8, 2015
A randomised double-blind placebo-controlled 12- week feasibility trial of methotrexate added to treatment as usual in early schizophrenia: study protocol for a randomised controlled trialImran B Chaudhry, Nusrat Husain, Raza ur Rahman, et al.
Rheumatology (Oxford, England)|January 29, 2019
Incidental significant arrhythmia in scleroderma associates with cardiac magnetic resonance measure of fibrosis and hs-TnI and NT-proBNPLesley-Anne Bissell, Raluca B Dumitru, Bara Erhayiem, et al.
Annals of the Rheumatic Diseases|March 13, 2014
A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trialJ L Nam, E Villeneuve, E M A Hensor, et al.
RMD Open|October 19, 2021
Cardiovascular outcomes in systemic sclerosis with abnormal cardiovascular MRI and serum cardiac biomarkersRaluca B Dumitru, Lesley-Anne Bissell, Bara Erhayiem, et al.
Annals of the Rheumatic Diseases|July 27, 2006
Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk testM H Buch, C P Denton, D E Furst, et al.
The Lancet. Rheumatology|October 17, 2025
Exploiting a unified vascular framework to predict organ-specific complications and accomplish disease modification in systemic sclerosisJohn D Pauling, Yannick Allanore, Maya H Buch, et al.
Rheumatology (Oxford, England)|September 18, 2016
Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA studyLesley-Anne Bissell, Elizabeth M A Hensor, Lukasz Kozera, et al.
Pageof 21